Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.
Bermejo F, Jiménez L, Algaba A, Vela M, Bastida G, Merino O, López-García A, Melcarne L, Rodríguez-Lago I, de la Maza S, Bouhmidi A, Barreiro-de Acosta M, López-Serrano P, Carrillo-Palau M, Mesonero F, Orts B, Bonillo D, Granja A, Guerra I. Bermejo F, et al. Inflamm Bowel Dis. 2022 Jan 5;28(1):41-47. doi: 10.1093/ibd/izab015. Inflamm Bowel Dis. 2022. PMID: 33528018
Usefulness of magnetic resonance enterography in the clinical decision-making process for patients with inflammatory bowel disease.
Ramos López L, Hernández Camba A, Rodríguez-Lago I, Carrillo Palau M, Cejas Dorta L, Elorza A, Alonso Abreu I, Vela M, Hidalgo A, Hernández Álvarez-Builla N, Rodríguez GE, Rodríguez Y, Tardillo C, Díaz-Flórez L, Eiroa D, Aduna M, Garrido MS, Larena JA, Cabriada JL, Quintero Carrion E. Ramos López L, et al. Gastroenterol Hepatol. 2020 Oct;43(8):439-445. doi: 10.1016/j.gastrohep.2020.03.007. Epub 2020 Apr 27. Gastroenterol Hepatol. 2020. PMID: 32349904 English, Spanish.
Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study.
Garcia-Romero R, Martinez de Zabarte Fernandez JM, Pujol-Muncunill G, Donat-Aliaga E, Segarra-Cantón O, Irastorza-Terradillos I, Medina-Benitez E, Ruiz-Hernández CJ, Carrillo-Palau M, Ros-Arnal I, Rodriguez-Martínez A, Escartin-Madurga L, Gutiérrez-Junquera C, Vicente-Santamaría S, Velasco Rodriguez-Belvis M, Fernández-Fernández S, Alberto-Alonso JR, Montraveta M, Torres-Peral R, Navalon-Rubio M, Navas-López VM, Martin de Carpi J. Garcia-Romero R, et al. Eur J Pediatr. 2021 Sep;180(9):3029-3038. doi: 10.1007/s00431-021-04063-6. Epub 2021 Apr 20. Eur J Pediatr. 2021. PMID: 33880650
Corrigendum to: Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.
Bermejo F, Jiménez L, Algaba A, Vela M, Bastida G, Merino O, López-García A, Melcarne L, Rodríguez-Lago I, de la Maza S, Bouhmidi A, Barreiro-de Acosta M, López-Serrano P, Carrillo-Palau M, Mesonero F, Orts B, Bonillo D, Granja A, Guerra I. Bermejo F, et al. Inflamm Bowel Dis. 2022 Jan 5;28(1):150. doi: 10.1093/ibd/izab242. Inflamm Bowel Dis. 2022. PMID: 34636902 No abstract available.
Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease.
Hernández-Camba A, Carrillo-Palau M, Ramos L, de Armas-Rillo L, Vela M, Arranz L, González-Gay MÁ, Ferraz-Amaro I. Hernández-Camba A, et al. Among authors: carrillo palau m. Clin Transl Gastroenterol. 2022 Jun 1;13(6):e00500. doi: 10.14309/ctg.0000000000000500. Clin Transl Gastroenterol. 2022. PMID: 35584319 Free PMC article.
Hematological Composite Scores in Patients with Inflammatory Bowel Disease.
Carrillo-Palau M, Vera-Santana B, Morant-Domínguez A, Hernández-Camba A, Ramos L, Alonso-Abreu I, Hernández Álvarez-Buylla N, Arranz L, Vela M, Hernández-Guerra M, Gómez-Moreno C, González-Gay MÁ, Ferraz-Amaro I. Carrillo-Palau M, et al. J Clin Med. 2023 Nov 23;12(23):7248. doi: 10.3390/jcm12237248. J Clin Med. 2023. PMID: 38068300 Free PMC article.
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry.
Calafat M, Torres P, Tosca-Cuquerella J, Sánchez-Aldehuelo R, Rivero M, Iborra M, González-Vivo M, Vera I, de Castro L, Bujanda L, Barreiro-de Acosta M, González-Muñoza C, Calvet X, Benítez JM, Llorente-Barrio M, Surís G, Cañete F, Arias-García L, Monfort D, Castaño-García A, Garcia-Alonso FJ, Huguet JM, Marín-Jímenez I, Lorente R, Martín-Cardona A, Ferrer JÁ, Camo P, Gisbert JP, Pajares R, Gomollón F, Castro-Poceiro J, Morales-Alvarado J, Llaó J, Rodríguez A, Rodríguez C, Pérez-Galindo P, Navarro M, Jiménez-García N, Carrillo-Palau M, Blázquez-Gómez I, Sesé E, Almela P, Ramírez de la Piscina P, Taxonera C, Rodríguez-Lago I, Cabrinety L, Vela M, Mínguez M, Mesonero F, García MJ, Aguas M, Márquez L, Silva Porto M, Pineda JR, García-Etxebarría K, Bertoletti F, Brunet E, Mañosa M, Domènech E. Calafat M, et al. Among authors: carrillo palau m. Therap Adv Gastroenterol. 2024 Jan 5;17:17562848231221713. doi: 10.1177/17562848231221713. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 38187926 Free PMC article.
41 results